Published
Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial
No abstract availability was recorded for this entry.
Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Bibliographic context
- Date
- 2019-01-01
- Source
- OpenAlex
- DOI
- Unavailable
- PubMed
- Unavailable
Derived topics and classifications
Citation graph
0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.
Related papers
PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trialInternational Journal of Gynecological Cancer · 2024-10-01Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depressionNature Mental Health · 2024-08-05Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-28Psychedelics: The New Kid on the BlockAnnals of Indian Psychiatry · 2024-01-01Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreatUniversität Zürich, ZORA · 2025-09-29Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-04-01Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04